Leukemia, Lymphocytic, B Cell
2 clinical trials · Condition
◉ Watch Leukemia, Lymphocytic, B Cell
| Record | Firm | Date |
|---|---|---|
| CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies (NCT03448393) | National Cancer Institute (NCI) | 2018-03-26 |
Track Leukemia, Lymphocytic, B Cell automatically
Every clearance here is in the API, with alerts when new ones post.